Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Milestone, Leukemia Clinical Trial Statistics

Donna Neuberg

ScD

🏢Dana-Farber Cancer Institute / Harvard T.H. Chan School of Public Health🌐USA

Professor and Director, Biostatistics Program

70
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Donna Neuberg has been the biostatistical partner for some of the most important leukemia and lymphoma clinical trials of the past three decades at Dana-Farber, contributing rigorous statistical frameworks that have ensured interpretability and validity of landmark studies. Her methodological contributions include novel approaches to survival analysis in cancer trials, competing risk analysis, and time-to-event endpoints in hematologic malignancy research. She has co-authored over 500 clinical trial publications.

Share:

🧪Research Fields 研究领域

clinical trial biostatistics
leukemia survival analysis
DFCI statistical methods
hematologic cancer trials
lymphoma survival endpoints

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Donna Neuberg 的研究动态

Follow Donna Neuberg's research updates

留下邮箱,当我们发布与 Donna Neuberg(Dana-Farber Cancer Institute / Harvard T.H. Chan School of Public Health)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment